美国 · SEC FORM 4
GILEAD SCIENCES, INC.
GILD · Nasdaq · CIK 0000882095 · Healthcare · Drug Manufacturers—General
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
86 同一窗口内观察到的 Form 4 交易行
44 sales · 42 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 21,828,725
- 上期报告
- 18,304,875
- 日均成交量
- 6,503,853
- 回补天数
- 3.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
163 transaction lines in the latest 365-day window; 759 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Mercier Johanna | 卖出 (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC 申报 ↗ |
| 2026-10-15 | Dickinson Andrew D | 卖出 (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC 申报 ↗ |
| 2026-10-01 | O'Day Daniel Patrick | 卖出 (S) | Common Stock | 15,000 | USD 147.90 | USD 2,218,508 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Mercier Johanna | 卖出 (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC 申报 ↗ |
| 2026-10-15 | Dickinson Andrew D | 卖出 (S) | Common Stock | 3,000 | USD 156.22 | USD 468,660 | SEC 申报 ↗ |
| 2026-10-01 | O'Day Daniel Patrick | 卖出 (S) | Common Stock | 15,000 | USD 147.90 | USD 2,218,508 | SEC 申报 ↗ |
| 2026-09-22 | Burkhart Erin | 期权行权／转换 (M) | Common Stock | 2,223 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-22 | Burkhart Erin | 代扣税 (F) | Common Stock | 768 | USD 152.67 | USD 117,251 | SEC 申报 ↗ |
| 2026-09-15 | Mercier Johanna | 卖出 (S) | Common Stock | 3,000 | USD 144.22 | USD 432,646 | SEC 申报 ↗ |
| 2026-09-15 | Dickinson Andrew D | 卖出 (S) | Common Stock | 3,000 | USD 145.29 | USD 435,870 | SEC 申报 ↗ |
| 2026-09-10 | O'Day Daniel Patrick | 期权行权／转换 (M) | Common Stock | 8,780 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-10 | O'Day Daniel Patrick | 代扣税 (F) | Common Stock | 4,230 | USD 144.81 | USD 612,546 | SEC 申报 ↗ |
| 2026-09-10 | Mercier Johanna | 期权行权／转换 (M) | Common Stock | 2,797 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-10 | Mercier Johanna | 代扣税 (F) | Common Stock | 1,347 | USD 144.81 | USD 195,059 | SEC 申报 ↗ |
| 2026-09-10 | Dickinson Andrew D | 期权行权／转换 (M) | Common Stock | 2,797 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-10 | Dickinson Andrew D | 代扣税 (F) | Common Stock | 1,347 | USD 144.81 | USD 195,059 | SEC 申报 ↗ |
| 2026-09-10 | Cain Wettan Keeley M | 期权行权／转换 (M) | Common Stock | 590 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-10 | Cain Wettan Keeley M | 代扣税 (F) | Common Stock | 285 | USD 144.81 | USD 41,271 | SEC 申报 ↗ |
| 2026-09-10 | Berger Dietmar | 期权行权／转换 (M) | Common Stock | 533 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-10 | Berger Dietmar | 代扣税 (F) | Common Stock | 263 | USD 144.81 | USD 38,085 | SEC 申报 ↗ |
| 2026-09-01 | O'Day Daniel Patrick | 卖出 (S) | Common Stock | 15,000 | USD 148.64 | USD 2,229,556 | SEC 申报 ↗ |
| 2026-08-26 | WELTERS ANTHONY | 卖出 (S) | Common Stock | 18,000 | USD 148.62 | USD 2,675,197 | SEC 申报 ↗ |
| 2026-08-26 | WELTERS ANTHONY | 期权行权／转换 (M) | Common Stock | 18,000 | USD 61.06 | USD 1,099,052 | SEC 申报 ↗ |
| 2026-08-20 | Bluestone Jeffrey | 卖出 (S) | Common Stock | 5,000 | USD 145.01 | USD 725,066 | SEC 申报 ↗ |
| 2026-08-20 | Bluestone Jeffrey | 期权行权／转换 (M) | Common Stock | 5,000 | USD 67.04 | USD 335,206 | SEC 申报 ↗ |
| 2026-08-17 | Mercier Johanna | 卖出 (S) | Common Stock | 28,000 | USD 137.64 | USD 3,854,045 | SEC 申报 ↗ |
| 2026-08-17 | Mercier Johanna | 期权行权／转换 (M) | Common Stock | 25,000 | USD 67.07 | USD 1,676,773 | SEC 申报 ↗ |
| 2026-08-17 | Dickinson Andrew D | 卖出 (S) | Common Stock | 3,000 | USD 138.36 | USD 415,080 | SEC 申报 ↗ |
| 2026-08-10 | Cain Wettan Keeley M | 期权行权／转换 (M) | Common Stock | 6,002 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-10 | Cain Wettan Keeley M | 代扣税 (F) | Common Stock | 2,908 | USD 133.06 | USD 386,938 | SEC 申报 ↗ |
| 2026-08-03 | O'Day Daniel Patrick | 卖出 (S) | Common Stock | 15,000 | USD 130.31 | USD 1,954,686 | SEC 申报 ↗ |
| 2026-07-15 | Mercier Johanna | 卖出 (S) | Common Stock | 3,000 | USD 129.92 | USD 389,760 | SEC 申报 ↗ |
| 2026-07-15 | Dickinson Andrew D | 卖出 (S) | Common Stock | 3,000 | USD 129.93 | USD 389,790 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | GILD |
| CIK | 0000882095 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—General Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 759 transaction lines from 2020-01-03 to 2026-10-15 0 P purchase lines · 179 S sale lines · 580 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.